Purple Haze CBD Flower
Purple Hemp Flowers
3 Mind CBD sachets
Purple Haze Analysis

Purple Haze (Greenhouse) - CBD 10,6%

Grown in a greenhouse in Switzerland, Purple Haze reveals fresh flowers from this year's harvest with notes of lavender, blueberry and wood. A highly aromatic Sativa-dominant hybrid with 10.6% CBD.
Regular price 13,80 € Sale price instead of 18,00 €

Availability: In stock – Ships within 24h

6,90 €/g
Tax included. Shipping calculated at checkout.
En Stock !
Livré en France sous 2 à 3 jours
Vous n'êtes pas en France ?

Summary

  • Grown in Switzerland in a greenhouse (Greenhouse)
  • Fresh and very fragrant flowers (this year's harvest)
  • Sativa-dominant hybrid
  • Flavours: Lavender, Blueberry, Wood
  • CBD 10.6%

See all products:

Details

Purple Haze CBD Hemp Flower 10.6%

Purple Haze is a highly sought-after CBD flower variety, often praised for its distinctive flavours. This beautiful flower comes from a Sativa strain and is best known for its deep purple hues, hence the name "Purple Haze".

Superb aroma, gorgeous colour and a particularly careful trim on this Sativa-dominant hybrid.

Cultivation method
Grown in a greenhouse, allowing precise control of growing conditions. The soil is rich in nutrients, and temperature and humidity are managed to support the plant's development.

Species
Sativa-dominant hybrid.

Concentration
CBD: 10.61%
THC: 0.23%

Certification
Product grown in the EU, then certified by a GMP-approved laboratory. The certificate of analysis for this product, carried out by a certified, independent European laboratory, is available among the photos on this page.

Legislation
100% legal product in the European Union. This variety is a hybrid derived from varieties authorised in the European catalogue.

*Photos are non-contractual, taken by us and from the batch currently on sale*

Aromas

Purple Haze CBD Flowers

  • Lavender
  • Blueberry
  • Wood

Similar products

Discover other Greenhouse CBD flowers with a similar CBD level:

Sources and references (4)

Official and scientific sources on the regulation, safety, composition and quality of this type of product. They are provided for information and are not health claims.

  1. MILDECA (2021). L'indispensable sur... le cannabidiol (CBD). MILDECA — drogues.gouv.fr. View the source
  2. MILDECA (2023). Le CBD. drogues.gouv.fr (Mission interministérielle de lutte contre les drogues et les conduites addictives). View the source
  3. Chevallier C, Charuel L, Richeval C, Chaouachi L, Del Valle L, Eiden C, Gaulier JM, Batisse A (CEIP-A Paris, Lyon, Montpellier ; CHU Lille) (2023). Cannabidiol : analyse de produits « CBD non pharmaceutiques » disponibles sur le marché en France. MILDECA — drogues.gouv.fr (rapport CEIP-A financé par la MILDECA). View the source
  4. Dryburgh LM, Bolan NS, Grof CPL, et al. (2018). Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects. British Journal of Clinical Pharmacology. View the source

Recently viewed